(Source: Business Wire)
Physio-Control, Inc., a wholly owned subsidiary of Medtronic, Inc.,
(NYSE: MDT) announced today it received approval by Health Canada to
market the LIFEPAK 15 monitor/defibrillator within Canada. Official
license notification was received on Sept. 1, 2009.
Physio-Control was granted CE mark in January 2009, certifying
compliance with the European Union Medical Device Directive and began
its U.S. market release of the LIFEPAK 15 monitor/defibrillator in March
2009.
The LIFEPAK 15 monitor/defibrillator builds on a 54-year Physio-Control
heritage of providing innovative, reliable equipment to lifesaving teams
around the world. With an all-new product platform, it delivers
best-in-class clinical and operational innovations and raises the bar on
the legendary LIFEPAK® standard for durability.
Clinically innovative, the LIFEPAK 15 provides the widest range
of energy dosing up to 360 joules, and the broadest selection of
monitoring options available. It continues Physio-Control's legacy of
industry firsts as the first monitor/defibrillator to integrate Masimo
Rainbow SET® Pulse CO-Oximetry technology for the
noninvasive detection of carboxyhemoglobin (carbon monoxide in the
blood; the leading cause of poisoning death in industrialized countries1)
and methemoglobin in the blood (which may result from exposure to
certain chemicals and drugs).
The design focuses on several key operational innovations which include
the largest color screen on the market, with a one-touch button that
flips the screen to high-contrast SunVue mode for easy viewing in
sunlight; along with 10 times the processing speed and three times the
battery life of its predecessor. Needed for the harshest rescue
environments, Physio-Control developed the LIFEPAK 15 to be tougher than
any other monitor/defibrillator on the market. For current LIFEPAK
customers, this model reduces transition costs, with a user interface
that complements the market-leading LIFEPAK 12 defibrillator/monitor.
Emergency care providers are able to work with a mixed fleet of LIFEPAK
monitors, and transition their equipment when budgets allowenabling
them to save on critical operational costs and minimize their overall
training resources.
"Physio-Control has been developing and refining monitoring and
defibrillation technology for more than 50 years. With the latest
approval for distribution by Health Canada the LIFEPAK 15 continues
to build momentum in the marketplace and is setting the new standard for
emergency care products," said Brian Webster, president of
Physio-Control.
